Bingliang Chen
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 7
- Immunology 11
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Co-authors
- Casey C. Case (4 shared papers)Yuxin Liang (4 shared papers)Edward J. Rebar (4 shared papers)Alan P. Wolffe (4 shared papers)Andrew C. Jamieson (3 shared papers)S. Kaye Spratt (3 shared papers)Zhihai Wu (11 shared papers)Weiwei Wu (9 shared papers)
- Journals
- Cancer Research (6 papers)Cancer Immunology Immunotherapy (3 papers)mAbs (2 papers)Nature Medicine (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Bingliang Chen
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Oncology 351
- Immunology 266
- Molecular Biology 540
- Cancer Research 86
- Radiology, Nuclear Medicine and Imaging 106
Countries citing papers authored by Bingliang Chen
This map shows the geographic impact of Bingliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingliang Chen more than expected).
Fields of papers citing papers by Bingliang Chen
This network shows the impact of papers produced by Bingliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingliang Chen. The network helps show where Bingliang Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 212 | |
| 2 | 2001 | 206 | |
| 3 | 2019 | 101 | |
| 4 | 2020 | 92 | |
| 5 | 2021 | 80 | |
| 6 | 2013 | 60 | |
| 7 | 2023 | 37 | |
| 8 | 2020 | 37 | |
| 9 | 2021 | 32 | |
| 10 | 2002 | 30 | |
| 11 | 2002 | 28 | |
| 12 | 2018 | 26 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 25 | |
| 15 | 2020 | 23 | |
| 16 | 2023 | 22 | |
| 17 | 2020 | 19 | |
| 18 | [The effect of exercise during hemodialysis on adequacy of dialysis]. | 2002 | 17 |
| 19 | 2024 | 13 | |
| 20 | 2020 | 12 |
About Bingliang Chen
Bingliang Chen is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Ferroptosis and cancer prognosis (8 papers), CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immunotherapy and Immune Responses (4 papers), Renal cell carcinoma treatment (3 papers), RNA Research and Splicing (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (351 citations), Immunology (266 citations), Molecular Biology (540 citations), Cancer Research (86 citations) and Radiology, Nuclear Medicine and Imaging (106 citations). Bingliang Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Casey C. Case, Yuxin Liang, Edward J. Rebar, Alan P. Wolffe, Andrew C. Jamieson, S. Kaye Spratt, Zhihai Wu, Weiwei Wu, Junjian Liu and Shuaixiang Zhou. Their work appears in journals such as Cancer Research, Cancer Immunology Immunotherapy, mAbs, Nature Medicine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.